After Week 48, 71% (2349/3313) of DART participants, excluding all participants who were enrolled in the STI sub-study had data collected for at least one of the biochemistry test results (including bilirubin, alanine amino transferase and aspartate amino transferase) or CD4 cell counts at their Week 96 visit and were included in these analyses. The gene discussed is CD4; the disease is sexually transmitted disease.